A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV
Maribel Rodriguez-Torres*, Eric M. Yoshida**, Patrick Marcellin***, Subasree Srinivasan****, Vivek S. Purohit****, Cunshan Wang****, Jennifer L. Hammond****,
Corresponding author
* Fundación de Investigación and San Juan Bautista School of Medicine, San Juan, Puerto Rico, USA
** University of British Columbia and Vancouver General Hospital, Vancouver, B.C. Canada
*** Service d’Hépatologie, Hôpital Beaujon, Université Paris-Diderot, Clichy, France
**** Pfizer, Global Innovative Pharma Business Unit, Groton, CT, and Collegeville, PA, USA
Read
3879
Timeswas read the article
487
Total PDF
3392
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 11 | 2 | 13 |
| 2025 11 | 65 | 25 | 90 |
| 2025 10 | 48 | 9 | 57 |
| 2025 9 | 38 | 41 | 79 |
| 2025 8 | 33 | 18 | 51 |
| 2025 7 | 89 | 16 | 105 |
| 2025 6 | 46 | 9 | 55 |
| 2025 5 | 32 | 5 | 37 |
| 2025 4 | 37 | 6 | 43 |
| 2025 3 | 35 | 3 | 38 |
| 2025 2 | 33 | 5 | 38 |
| 2025 1 | 23 | 2 | 25 |
| 2024 12 | 24 | 0 | 24 |
| 2024 11 | 37 | 1 | 38 |
| 2024 10 | 42 | 1 | 43 |
| 2024 9 | 75 | 1 | 76 |
| 2024 8 | 10 | 3 | 13 |
| 2024 7 | 90 | 2 | 92 |
| 2024 6 | 15 | 0 | 15 |
| 2024 5 | 31 | 1 | 32 |
| 2024 4 | 30 | 6 | 36 |
| 2024 3 | 30 | 5 | 35 |
| 2024 2 | 28 | 1 | 29 |
| 2024 1 | 26 | 2 | 28 |
| 2023 12 | 35 | 2 | 37 |
| 2023 11 | 23 | 7 | 30 |
| 2023 10 | 96 | 4 | 100 |
| 2023 9 | 63 | 1 | 64 |
| 2023 8 | 38 | 2 | 40 |
| 2023 7 | 173 | 2 | 175 |
| 2023 6 | 208 | 2 | 210 |
| 2023 5 | 82 | 2 | 84 |
| 2023 4 | 52 | 0 | 52 |
| 2023 3 | 58 | 0 | 58 |
| 2023 2 | 433 | 2 | 435 |
| 2023 1 | 11 | 1 | 12 |
| 2022 12 | 17 | 5 | 22 |
| 2022 11 | 14 | 3 | 17 |
| 2022 10 | 16 | 5 | 21 |
| 2022 9 | 381 | 5 | 386 |
| 2022 8 | 241 | 6 | 247 |
| 2022 7 | 13 | 5 | 18 |
| 2022 6 | 14 | 5 | 19 |
| 2022 5 | 14 | 4 | 18 |
| 2022 4 | 25 | 9 | 34 |
| 2022 3 | 19 | 10 | 29 |
| 2022 2 | 23 | 9 | 32 |
| 2022 1 | 24 | 13 | 37 |
| 2021 12 | 15 | 10 | 25 |
| 2021 11 | 20 | 17 | 37 |
| 2021 10 | 23 | 11 | 34 |
| 2021 9 | 20 | 9 | 29 |
| 2021 8 | 19 | 6 | 25 |
| 2021 7 | 21 | 12 | 33 |
| 2021 6 | 10 | 12 | 22 |
| 2021 5 | 8 | 8 | 16 |
| 2021 4 | 90 | 16 | 106 |
| 2021 3 | 23 | 7 | 30 |
| 2021 2 | 6 | 7 | 13 |
| 2021 1 | 8 | 10 | 18 |
| 2020 12 | 12 | 4 | 16 |
| 2020 11 | 19 | 7 | 26 |
| 2020 10 | 20 | 4 | 24 |
| 2020 9 | 18 | 9 | 27 |
| 2020 8 | 6 | 3 | 9 |
| 2020 7 | 3 | 2 | 5 |
| 2020 6 | 4 | 3 | 7 |
| 2020 5 | 3 | 4 | 7 |
| 2020 4 | 1 | 3 | 4 |
| 2020 3 | 4 | 0 | 4 |
| 2020 2 | 3 | 5 | 8 |
| 2020 1 | 5 | 1 | 6 |
| 2019 12 | 5 | 5 | 10 |
| 2019 11 | 5 | 1 | 6 |
| 2019 10 | 2 | 5 | 7 |
| 2019 9 | 4 | 6 | 10 |
| 2019 8 | 2 | 5 | 7 |
| 2019 7 | 1 | 12 | 13 |
| 2019 6 | 11 | 15 | 26 |
Show all
